Acalabrutinib D4 is a deuterium-labeled version of acalabrutinib, a pharmaceutical compound used in research and pharmaceutical manufacturing. Its structure incorporates four deuterium atoms on the pyridine ring, which aids in analytical studies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2699608-18-7
Pristinamycine
antibiotic mixture
(1beta,2beta)-17-(Acetyloxy)-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione
Active pharmaceutical ingredient
Glutathione disulfide
active pharmaceutical ingredient
TILIDINE HYDROCHLORIDE
Analgesic active pharmaceutical ingredient
Acalabrutinib
Bruton's tyrosine kinase inhibitor
Acalabrutinib enantiomer
active pharmaceutical ingredient
Acalabrutinib maleate
Bruton's tyrosine kinase inhibitor
Acalabrutinib maleate monohydrate
active pharmaceutical ingredient
4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(3,4,5,6-tetradeuterio-2-pyridinyl)benzamide
WDENQIQQYWYTPO-FJSIYNKGSA-N
[2H]C1=C(C(=NC(=C1[2H])NC(=O)C2=CC=C(C=C2)C3=C4C(=NC=CN4C(=N3)[C@@H]5CCCN5C(=O)C#CC)N)[2H])[2H]